Ionis Pharmaceuticals (IONS) Income Statement
Ionis Pharmaceuticals Income Statement
Last quarter (Q2 2026), Ionis Pharmaceuticals's total revenue was $267.95M, a decrease of 40.73% from the same quarter last year. In Q2, Ionis Pharmaceuticals's net income was $-114.65M. See Ionis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 944.00M | $ 705.14M | $ 787.65M | $ 587.37M | $ 810.46M | |
| $ 928.00M | $ 693.92M | $ 778.51M | $ 573.25M | $ 799.61M | |
| $ 1.31B | $ 1.17B | $ 1.13B | $ 983.44M | $ 829.80M | |
| Depreciation and Amortization | $ 22.69M | $ 21.99M | $ 22.50M | $ 22.11M | $ 19.56M |
| $ -284.31M | $ -353.72M | $ -235.87M | $ -227.76M | $ -5.19M | |
| $ -382.00M | $ -475.08M | $ -353.73M | $ -410.19M | $ -30.19M | |
| $ 2.00M | $ 15.01M | $ 19.77M | $ 152.21M | $ 1.04M | |
| $ -380.00M | $ -460.07M | $ -333.96M | $ -257.99M | $ -29.15M | |
| $ -381.00M | $ -453.90M | $ -366.29M | $ -269.72M | $ -28.60M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.38 | $ -3.04 | $ -2.56 | $ -1.90 | $ -0.20 |
| Diluted EPS | $ -2.38 | $ -3.04 | $ -2.56 | $ -1.90 | $ -0.20 |
| Weighted Average Shares Outstanding | 160.00M | 149.51M | 143.00M | 141.85M | 141.02M |
| Weighted Average Shares Outstanding (Diluted) | 160.00M | 149.51M | 143.19M | 141.85M | 141.02M |
Currency in USD